Study Evaluating Bifeprunox in Patients With Schizophrenia.
Clinical trial NCT00366327 · TERMINATED
Trial details
- NCT number
- NCT00366327
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-01-01
- Primary completion
- 2008-03-01
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.